Mineralocorticoid receptor antagonist and methods of use

Details for Australian Patent Application No. 2010222902 (hide)

Owner Eli Lilly and Company

Inventors Coates, David Andrew; Gavardinas, Konstantinos; Jadhav, Prabhakar Kondaji

Agent Spruson & Ferguson

Pub. Number AU-A-2010222902

PCT Pub. Number WO2010/104721

Priority 61/159,578 12.03.09 US

Filing date 4 March 2010

Wipo publication date 16 September 2010

International Classifications

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/4184 (2006.01)

A61K 31/5383 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/40 (2006.01) Drugs for disorders of the endocrine system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

11 August 2011 PCT application entered the National Phase

  PCT publication WO2010/104721 Priority application(s): WO2010/104721

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010222905-Method for integrating reservoir charge modeling and downhole fluid analysis

2010222898-System and method for payload encoding and decoding